Market Access/ News/ News/ News/ News/ Oncology/ R&D/ R&D Big pharma could turn to viruses to boost cancer immunotherapies Richard Staines cancer, cancer immunotherapy, Merck & Co, R&D, Targovax, Viralytics 0 Comment Norwegian biotech looking for development partners Share X Big pharma could turn to viruses to boost cancer immunotherapies https://pharmaphorum.com/news/big-pharma-turn-viruses-boost-cancer-immunotherapies/